Alport syndrome is a hereditary condition primarily affecting the kidneys, characterised by irregularities in the synthesis of type IV collagen, which is essential for the integrity of the glomerular ...

Kobe University ISHIMORI Shingo and his team found that the most common reason why patients were referred to hospital for testing for Alport syndrome was due to age-3 urine screening results. In ...

LEXINGTON, Ky. (FOX 56) — Imagine learning your child needs a kidney transplant to survive. Now, imagine your other child needs one too, and so do you. The three have a rare genetic disease called ...

Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") is pleased to announce the company is providing financial support for the Alport Syndrome Registry Study organized by the Japanese ...

Renalys Pharma, Inc. (Headquarters: Tokyo; Representative Director Chaiman & CEO; BT Slingsby; "Renalys") and Chugai Pharmaceutical Co., Ltd. (Headquarters: Tokyo; President & CEO: Osamu Okuda; ...

KOCHI: When Aluva Marampally native Manoj walked out of Rajagiri Hospital with his son Akshay on Saturday, it marked the ...

ZyVersa is developing Cholesterol Efflux Mediator™ VAR 200 to mediate removal of damaging excess cholesterol and other lipids from the kidneys’ filtration system. VAR 200 directly removes lipids from ...

As the industry's competition in the rare kidney disease IgA nephropathy (IgAN) heats up in the U.S., Roche’s Chugai Phar | Last year, Japan's Renalys picked up certain Asian rights to the IgAN ...

Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") today announced that it has reached an agreement with the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan regarding ...

The most common first diagnosis of Alport syndrome in Japan is during the universal age-3 urine screening. In 60% of these children, the disease had already progressed far enough to qualify for ...